Aclarion, Inc. (ACON)

NASDAQ: ACON · IEX Real-Time Price · USD
-0.26 (-15.88%)
At close: May 24, 2022 4:00 PM
-0.02 (-1.45%)
After-hours:May 24, 2022 6:51 PM EDT
Market Cap10.79M
Revenue (ttm)58,287
Net Income (ttm)-2.32M
Shares Out7.82M
EPS (ttm)-0.30
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close1.64
Day's Range1.35 - 1.76
52-Week Range1.26 - 4.05
Price Targetn/a
Earnings Daten/a

About ACON

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), and a proprietary biomarker to optimize clinical treatments. The first application of Aclarion’s technology addresses the $134.5B U.S. low back and neck pain market. The Company, which has limited sales to date, is addressing this market by initially focusing on improving the outcomes of surgical interventions to treat low back pain. In this initial application, Aclarion technology is intended to assist surgeons in determining the optimal s...

IndustryHealth Information Services
IPO DateApr 22, 2022
CEOBrent Ness
Stock ExchangeNASDAQ
Ticker SymbolACON
Full Company Profile

Financial Performance

In 2021, Aclarion's revenue was $60,292, an increase of 23.93% compared to the previous year's $48,652. Losses were -$4.95 million, 6.80% more than in 2020.

Financial Statements


Aclarion IPO Registration Document (S-1)

Aclarion has filed to go public with an IPO on the NASDAQ.

4 months ago - SEC